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INTRODUCTION 
Research on the effects of lead has been conducted in 
domestic and laboratory animals, ··examining absorption, metab-
olism, excretion, and toxic effects. Lead has been adminis-
tered in various chemical forms via a number of routes of 
exposure, with particular emphasis on efforts to establish 
levels which may adversely affect neonatal development. 
However, conflicting. evidence has been reported in the 
ii tera ture concerning lead' s fetotoxic and t·eratogenic 
effects in hamsters, mice, and rats. This research project 
was designed to investigate the effects of lead acetate on 
fetal developme.nt of rats. Specific attention was directed 
-
towards teratogenicity, fetal toxicity, and neuro-DNA 
synthesis. These experiments differ from most previously 
reported research in that lead exposure and blood values 
were established and maintained throughout breeding and ges-
tation. Lead dosing simulated a more natural route of expo-
sure through oral gavage in constrast to some experimental 
methods involving intravenous, intra-amnion, o:i: intraperito-
ne.al injection (Kruckenberg et al., 1976; McClain and Becker, 
1972; McClain and Becker, 1975). 
Lead has been reported to adversely affect learning in 
sheep and children exposed to chronic low levels. Carson 
et al. (1974) demonstrated visuomotor deficits in lambs 
2 
prenatally exposed to lead. These observations ra.ise a 
. ·question--does lead exposure during fetal development cause 
a reduction in total brain cell numbers? In this experiment 
total brain DNA was measured as an indication of tota.l cell 
numbers. 
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LITERATURE REVIEW 
General Considerations of Lead 
Lead is considered a metallic poison that primarily 
enters the body through the gastrointestinal tract and respi-
ratory system. The major route of absorption of lead salts 
is the gastrointestinal tract. Most C!!Ses of lead intoxi-
cation in children and farm animals result from oral lead 
consumption (Allcroft and'Blaxter, 1950; Chisolm and. Kaplan, 
1968). From the gastrointestinal tract lead is either passed 
into the blood or is excrete.d in fecal matter. Therefore, 
the rate of excretion through the bowel appears to be the 
governing factor.influencing the absorption of lead by this 
route. The respiratory tract is the second major route of 
lead absorption. Early work with lead by Blumgart (1923) and 
Minot (1924) demonstrated that lead can be absorbed from all 
portions of the respiratory tract, including the nasal pas-
sages. Absorption via the respiratory system is more rapid 
and complete than through the gut, perhaps due to the high 
carbon dioxide tension present which creates an acid medium 
aiding solubility of the lead particles (Harvey, 1975). 
Inorganic lead is very slightly, if at all, absorbed 
through the in tact skin (Aub et al. , 19 24) • However, 
organic lead (tetraethyl lead) is readily absorbed dermally 
(Kehoe et al., 1935). 
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Many cases of lead poisoning are induced by the absorp-
tion of large quantities of lead over relatively short 
periods of time. This is classified as acute lead.poisoning, 
which contrasts with chronic lead poisoning. Acute poisoning 
often occurs if the amount of lead ingested is so great that 
the excretion capacity of the renal system is exceeded.. When 
this point is reached, lead is absorbed into the body tissues 
(Landown et al.; 1974). 
Absorbed lead is first deposited in the blood and soft 
tissue and then eventually in bone. Deposition into body 
tissues is partly governed by the chemical structure of the 
specific lead compounds, with deposition being more rapid in 
the case of organic than with inorganic compounds. The depo-
sition of lead in tissues appears to be regulated by the same 
physiologic mechanisms that control the metabolism of calcium 
and phosphorus (Shields and Mitchell, 1941: Six and Goyer, 
1970). Absorbed lead follows calcium to the bone, where 
over 90 percent is deposited in a nondiffusible form as a 
tri-lead phosphate (Schroeder and Tipton, 1968). Only a 
small percentage remains in the soft tissues and blood. 
Since lead is tightly bound in bone, it leaves the skeleton 
very slowly. 
Other physiopathologic effects of lead have been 
reported in several recent books, theses and review articles 
that provide detailed information concerning the biologic 
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influence of lead in hemesynthesis,, erythrocyte morphology 
and function, immune response and renal function (National 
Academy of Sciences, 1972: DeBruin, 1971: Goyer and Rhyme., 
1973: Hemphill, 1973: and Lassen, 1976). 
Elimination of lead occurs through urine, feces, and 
milk. It is also minimally excreted in sweat, the concen-
tr?-ticm being similar to that found in urine (Berman,. 1966). 
Kehoe et al. (1935) reported that in man a daily lead excre-
tion greater than 0.6 mg represents abnormal exposure for 
humans. After absorption has ceased, the rate of excretion 
of lead depends mainly on the rate of its mobilization from 
skeleton deposits •. At best, lead is slowly removed from 
the body (Kehoe ~nd Thamann, 1929). Absorbed lead is 
normally excreted in bile and eliminated in the feces 
(Klaassen and Shoeman, 1974). Under excessive exposure,· 
or when chelation therapy is employed; urinary excretion of 
lead is increased. Lead is excreted in the milk of both 
man and animals. The range of nQrmal values of lead in 
milk of humans and cattle is below 0.05 mg/l and 0.01 mg/l, 
respectively (Hammond and Aronson, 1964: Kehoe· et ·a1., 1940}. 
Figure 1 is a modified schematic flowchart as presented by 
Goyer and Chisolm (1972), which summarizes lead exposure, 
absorption, excretion, and biologic effects. 
6 
Oral intake 
G. I. a!aorption~~~---'~Feces (bile) 
Inhalation 
·=rtio• 
Liver 
1 1 Blood~~~~~Red bl1od calla 
.-~~~;_~~~~~~~Pl sma~~~~~-.Bone 
CN j Ence~~heral ' 
lopathy.. neuropathy 
Retic1 ocytea 
Anemia 
"'T' 
Tubular 
. dyafJction 
Urinary 
excretion 
Misce laneous 
effects 
l 
Endocrine 
Reproductive 
Cytogenic 
Al:imentary 
Figure 1. Schematic of lead exposure, absorption, excretion, 
and biologic effects (Modified from Goyer and 
Chisolm, 1972) 
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Neuropathologic Effects of Lead Exposure 
The need for understanding the neurotoxic effects of 
lead exposure became salient with the apparent connection 
to mental retardation and plumbism of lead exposed children 
(Chisolm and.Harrison, 1956; Landrigan et al., 1975; Smith 
et al., 1963). Researchers have used a variety of measure-
ment techniques in appropriate animal models to assess the 
different neuropathologic effects. These techniques have 
ranged from macro and microscopic anatomical evaluation to 
DNA measurement and cellular enumeration. 
Pentschew and Garro (1966) first introduced an experi-
mental model of lead encephalopathy. They reported that when 
neonatal rats were poisoned through suckling mothers which 
were fed a diet.containing 4 percent lead carbonate, neuro-
logic changes were characterized by capi·llary .dilation, 
glial proliferation, areas of transudation and spotty 
hermorrhages. The resultant neurologic damage produced was 
considered secondary to the cerebral edema observed. 
Thomas et al. (1971) also produced encephalopathy in 
suckling rats by adding 4.5 percent lead acetate to the feed 
and 1.0 percent lead acetate to the drinking water. Using 
light and electron microscopic techniques the researchers 
observed edema, endothelial swelling, and abnormalities in 
Purkinje cells. Similarly, Rosenblum and Johnson {1968) 
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produced encephalopathic lesions in mice, consisting of 
abnormally large numbers of fibrous intercapillary strands 
in severai cerebral loci and astrocytosis of the hippocampus. 
Thomas and Thomas (1974) reported lead induced encepha-
lopathic lesions in the brains of newborn rats. The lesions 
were distinctly observed in the cerebellum, and consisted of 
al:terations in capillary endothelial cells, the formation of 
platelet thrombi and scattered areas of hemorrhage and 
edema. 
Krigman et al. (1974) induced lead encephalopathy in 
rats by adding. 4 percent lead carbonate to the diet of 
nursing mothers. They reported that lead intoxication was 
associated with ~etardation of neural tissue growth without 
reduction of cell populations, alteration of myelin forma-
tion and a size reduction in neuronal axons. The number of 
myelin lamellae in the sheaths, however, was reduced. 
Michaelson and Sauerhoff (1974) indicated there may 
be a possible link between malnutrition and lead exposure 
which causes paraplegia and cerebellar vascular damage in 
the suckling rat. They proposed an improved model 
for differentiation between encephalopathy caused 
by malnutrition and that caused by lead exposure. 
Michaelson (1973) intoxicated newborn rats by in-
cluding lead acetate in the diet of nursing animals on the 
.9 
day·of birth and further reported that within the cerebellum 
there was extensive capillary breakdown and hemorrhage. 
Arrested body growth, .ataxia, and paraplegia were ;i.lso 
reported. Additionally, a 15 to 20 percent deficit in new 
cell formation in the cerebellum was found as measured by 
DNA content atthrel:! weeks of.age; DNA content has been 
reported to be constant within a single diploid cell in any 
species (Hotchkiss, 19551 Vendrely, 1955). It is possible 
to calculate the number of diploid cells in an organ by 
analyzing for total organ DNA and dividing by DNA per cell 
(Enesco and Leblond, 19621 Winick and Noble (1965). Using 
this technique, DNA has come to be used 1 as a reference 
standard for cal9ulating the number of cells present. 
Placental Transfer and Fetal Tissue Absorption 
The transfer of lead across the human placenta and its 
potential threat to the conceptus have been recognized for· 
over a century. Early evidence of this problem resulted 
from reports that women working in lead industries commonly 
exhibited unusually high rates of sterility, spontaneous 
abortion, and stillbirths (Carpenter, 1974). Some early 
work clearly demonstrated the presence of lead in fetal 
tissues and left little doubt that the human placenta was 
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permeable to this toxic metal (Karlog and Moller, 1958; 
Kehoe et al., 1935). 
A more recent study by Barltrop (1969) was conducted 
on apparently normal humans and indicated that placental 
transfer of lead began early in gestation and that the total 
lead content in fetal tissues increased throughout pregnancy. 
A typical adult distribution of lead was found in fetuses 
with the highest concentrations in bone and liver, but there 
were also significant amounts in kidney, brain, and placenta. 
Barltrop further noted that the location of lead within the 
fetus at different stages of gestation is probably of far 
greater importance than the total amount present at tertn. 
Work that has be_en conducted on transplacental movement of 
lead in humans indicates that the lead content of the 
umbilical cord is approximately equal to the maternal blood 
lead level of 10 to 20 µg/100 ml (Gershanik et 'al., 1974; 
Harris and Holley, 1972). 
Early work by Baumann (1933) demonstrated. the first 
placental transfer of lead in a mammal. Pregnant rats were 
injected with very small doses (0.01 µg) of radioactive 
lead c212Pb) .and its distribution in the mother and fetus 
was observed via autoradiography. Lead rapidly crossed the 
placenta and localized within the fetal tissues, primarily 
developing bone. Another early study in dogs by Calvery 
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et al •. (1938) confirmed the permeability of mammalian pla-
centa to lead. 
Green and Gruener (1974) studied the.kirietics. of 
maternal•fetal transfer of lead in the rat. They reported 
that lead was transferred at different stages of gestation 
and its transport was so rapid that the fetus was in equil-
, ibrium with the dam 24 hours after injection. 
Hubermont et·al. · (1976) ·administered lead ·nitrate to 
female rats in-drinking water at 0.1, 1, and 10 ppm_ for three 
weeks before mating, during pregnancy, and three weeks after 
delivery. In maternal animals a significant increase in 
blood lead concentration and lead concent,ration in kidney 
was found in the_lO ppm group. In newborns, lead concen-
trations in blood and in kidney were also significantly 
increased in the 10 ppm group. 
Barltrop et al. (1971) examined the subcellular distri-
bution of lead in four fetal soft tissues: heart, liver, 
spleen and kidney. Labeled lead chloride wa:s intraperi-
toneally administered to 6 rats and tissue was collected at 
intervals between 2 hours and 14 days following administra-
tion. The spleen and kidney contained considerable amounts 
of lead; the liver contained relatively less; and the heart 
contained very little. 
Singh et al. (1976) fed rats 100 and 200 mg of Pb(N0
3
l 2 
per kilogram body weight before and during pregnancy. Mean 
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blood lead values for pregnant female rats prior to delivery 
were 65 and 75 µg/100 ml, respectively. Lead content in 
pups just after birth was higher in kidney than in the 
liver, with brain unusually high (910 µg per 100 g of 
brain) • Singh further hypo.thesized that since the brain is 
exceptionally sensitive to the effects of lead poisoning, 
as stated in Goyer and Rhyme's review (1973), this high 
amount of lead found within the brain suggests the possi-
bility of brain abnormalities being developed during 
gestation. 
Reproductive Effects of Lead 
Lead has been incriminated in reduced fertility, 
abortion, and neonatal death in man and animals. Flury 
(1934) reported disturbances in the menstrual cycle in 
women poisoned with lead and observed development of transi-
tory sterility in women lead workers. Normal fertility 
returned after cessation of exposure to lead. 
Pindborg (1945) observed in Danish women that lead 
oxide, when orally ingested, was an abortifacient. He 
reported 60 percent of the pregnancies ended in abortion 
in the first trimester. Wilson (1966) more recently 
reported human abortion to be associated with lead in 
drinking water .and high fetal tissue lead levels. James 
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et al. (1966) fed lead acetate at a rate of 9 mg/kg for 45 
days of gestation, causing abortion and subsequent maternal 
death in sheep. Sharma (1971) also reported abortion, 
resorption, and failure t_o breed when sheep were fed an 
average of 11.8 mg lead/kg/day prior to and during 
gestation. 
Stowe and Goyer (1971) found that either paternal-only 
or maternal-only lead exposure resulted in a reduction in 
the number of rat pups per litter, a retardation in mean 
pup birth -weight, and a reduction in pup survival. These 
effects were magnified in offspring whose parents both had 
been exposed to lead. 
Hilderbrand_.et al. (1973) monitored the reproductive 
estrus cycles of 60 sexually mature rats exposed to 5 µg 
and 100 µg lead acetate per. day for 35 days. The feniales· 
treated with 5 µg experienced irregularity of the estrus 
cycle, while the group treated with +oo µg had persistent 
vaginal estrus after a period of normal estrus and the 
development of ovarian follicular cysts with a reduction in 
the number of corpora lutea also noted. 
Vermande-van Eck and Meigs (1960) have also reported 
that the ovaries of lead burdened rhesus monkeys had a 
reduced number of developing follicles. 
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Teratogenic.Effects.of Lead 
Lead has been administered in various forms, via a 
number of routes in efforts to establish exposure levels 
which may adversely affect mammalian embryonic 
development. 
Ferm and Carpenter (1967) administered lead nitrate, 
lead chloride, and lead acetate in 50 mg/kg intravenous 
doses to hamsters on either day 7, B, or 9 of pregnancy. 
Fetal examination between day 12 and 15 of the 16-day 
gestation p.eriod found specific congenital skeletal mal-
formations localized within the developing sacral and 
coccygeal vertebra. In similar studies, Carpenter ·et al. 
(1973) and Ferm and Ferm (1971) -administered lead nitrate 
intravenously at doses of 25 and 50 mg/kg to maternal 
hamsters during 5 equal time periods of the eighth and 
ninth days of gestation. Teratogenic effects of lead were 
restricted to the developing tail bud. Increased incidence 
of embryonic resorption and malformation proportionately 
paralleled increased lead exposure. 
Schroeder and Mitchener (1971) examined the toxic 
effect of several trace elements on reproduction in mice 
and rats in a multi-generation study. Lead, continuously 
administered at 25 ppm in the drinking water was found to 
severely depress reproduction in mice. Most of the lead 
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exposed mice died and consequently were incapable of repro-
duction. From the five lead exposed mice originally allowed 
to breed, only eight first generation, and two. viable second 
generation· litters were produced in a 6-month period. Of 
the 72 live offspring in the first generation, 69 were runts, 
9 died, and 4 matured to breeding age. Lead was also found 
to be toxic to breeding rats, but less so than to mice. In 
the first generation·of rat offspring, there were.12 deaths, 
and 40 runts in 19 litters containing 173 progeny. The 
second and third' generation animals also ·produced litters 
in which runts and deaths were common. 
McClain and Becker (1972) reported that tetraethyl lead 
(TEL), tetramethyl lead (TML), and tri-methyl lead chloride 
(Tri Mt) were found to be essentially nonteratogenic in 
Sprague-Dawley rats. Orally administered doses of TEL 
(7.5, 15, or 30 mg/kg), TML (40, 80, 112, or 160 mg/kg), 
and Tri ML (15, 30, and 38 mg/kg) were given as three 
divided doses during early organogenesis or late organo-
genesis of gestation. The highest doses of each compound 
resulted in maternal death, and lower doses produced a 
dose-related fetal growth retardation and delayed ossifi-
cation of bone. 
In a similar study, Kennedy et al. (1975) treated 
pregnant albino mice and rats by gavage with doses of lead 
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acetate up to 714 mg/kg or tetraethyl lead (TEL) at 10 
mg/kg. The compounds were administered daily during the 
period of rapid organogenesis. Maternal toxicity was 
observed and fetal resorption, as well as retardation of 
development, were encountered at higher dose levels. 
Fetuses from lead exposed females were examined grossly 
for internal structural and skeletal development, but no 
teratogenic responses were evident. 
McClain and Becker (1975) intravenously injected lead 
nitrate into pregnant rats in single doses of 25, 30, 50, 
or 70 mg/kg on each of days B through 17 of gestation. 
Treatment on day 9 of gestation resulted in grossly deformed 
fetuses with ma~formations including absent or shortened 
tail, sirenoform monsters, absence of posterior portions of 
the body, urorectal defects, soft tissue anomalies of 
the urogenital system, and axial skeletal defects. Adminis-
tration of lead on day 16 produced hydrocephalus and hemor-
rhage of the central nervous.system. 
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MATERIALS AND METHODS 
Prestudy 
A prestudy composed of 2S rats was conducted to estab-
lish some basic information concerning lead dosage as re-
lated to blood lead levels, effects of the gavage technique 
of dosing on reproduction, and to determine whether suffi-
cient maternal and fetal tissues were available for lead 
and DNA analyses. Additionally, the prestudy provided 
experience with analytical procedures and familiarized the 
experimenter with the potentially fatal blood collecting 
and dosing techniques. 
The oral do~age levels used in the prestudy were O, 
JS, so; 7S, and 100 mg/kg. Following lead exposure from 
two weeks to two months, the virgin females were bred to 
unexposed males, resulting in the pregnancy of twenty-one 
of twenty-five animals. Those that did not conceive were 
in the SO and 7S mg/kg dosage groups. The ave]'.'age number of 
pups per lit;ter was 9. Weekly blood lead analyses resulted 
in levels between 40 and 120 µg/dl in animals given SO, 7S, 
and 100 mg/kg lead as lead .acetate. Dissection and weighing 
of maternal and fetal tissues indicated that lead and DNA 
analyses were feasible. 
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Experimental Animals, Facilities and Maintenance 
Ten virgin male and forty virgin female hooded rats1 . 
were used as subjects. Upon receipt, each animal was ran-
domly assigned to an individual cage2 and allowed a two-
month acclimation period. All animals were maintained on 
a commercial laboratory ration3 and water, both of which 
were available ad libitum. The average background levels 
of lead in.feed and water were found to be 2.3 ppm and 6.0 
ppb, respectively. The colony room utilized throughout the 
experiment was adequately ventilated and concealed from out-
side light. The ambient temperature of this room ranged 
between 21.l-23.9°C. Standard fluorescent laboratory 
lighting was utilized in a constant 10-hour light, 14-hour 
dark cycle. Each animal was handled daily beginning on day 
one of the experiment for daily oral gavage. 
Experimental Design 
The following design was developed to accommodate three 
replicates with four levels of exposure per replicate. On 
day 0 of the experimental period following acclimation, all 
1Long-Evans strain; Blue Spruce Farms, Altamont, NY. 
2cage dimensions: B"W x 7"D x lO"H. 
3wayne Lab-Blox Shorts; Allied Mills, Inc., Chicago, IL. 
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40 animals were individually weighed. Thirty-six females 
were then randomly assigned to an exposure level within a. 
replicate. Each tier of the cage rack1 housed four animals, 
alternating an empty cage, thereby minimizing cross-contam-
inat;i.on and eliminating coprophagy. 
Lead Exposure 
Blood lead levels and desired length of· exposure were 
determined by the.prestudy. Each experimental animal was 
randomly assigned to one of four groups which received daily 
dosages of lead as acetate at either O, SO, 7S, or 100 mg/kg 
body weight. Care .was taken to control for dosage volume 
across exposure groups. All rats within each replicate were 
weighed daily. The highest body weight in the 100 mg/kg 
body weight treatment level.was used to calculate the daily 
administered volume. This daily dose volume was determined 
by calculating the required amount of lead based on a weekly 
prepared stock solution of lead acetate. Dose volumes given 
to each rat within a replicate were made equal by adding 
double distilled water to the calculated lead solution 
volume for levels O, SO, and 7S mg/kg body weight. The 
total daily dose volume of lead solution and water never 
exceeded 2 ml per dose. 
1Becton-Dickinson and co., Rutherford, NJ. 
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The measured doses of lead acetate solution were admin-
istered by gavage. This insured that precise amounts of 
lead were administered. Gavage intubation was ac~ieved 
with an 18-gauge curved ball-tipped feeding needle (2 1/4 mm 
ball) 1 attached to sterile disposable 3 ml syringes·. Dosage 
was calculated following a weekly chemical analysis of 1,000 
ml of lead acetate stock solution. To prevent possible 
transfer of disease organisms or residual lead accumulation, 
each replicate of the test had its own gavage apparatus 
which was cleaned daily following dosing, with a dilute 
nitric acid solution. 
Estrous Cycle and Breeding 
Vaginal smears were taken daily from female rats 
beginning seven days prior to lead exposure and continuing 
·until.day 6 of pregnancy. Individual records were kept for 
each animal to establish its estrous cycle. After lead 
exposure for three weeks, females showing pro-estrus were 
individually introduced overnight to one male. 
Sperm or vaginal plugs present the following morning 
determined day zero of pregnancy. Vaginal smears indicating 
diestrous and mid-ventral laparotomies on day 6 further 
substantiated pregnancy. 
1 Popper & Sons, Inc. , New Hyde Park, NY • 
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Maternal Tissue Examination and Preparation 
A blood sample was collected pr~Gr to initiai exposure 
and subsequent blood samples were collected every two weeks. 
Each animal was anesthetized with ether and the blood 
collected from the. orbital sinus utilizing a 100 µl 
capillary tube. Approximately 1.5 ml· of blood was· taken 
and placed in heparinized lead-free vacutainers. 1 The 
samples were immediately shaken and refriger~ted at 43°C 
until analyzed for lead. 
On day 20 of gestation, each female rat was euthanized 
with ether and 2 ml of whole blood was taken for lead 
analysis. The maternal liver and kidneys were excised, 
weighed and stored frozen for subsequent lead analysis. The 
reproductive tract was removed, including ovaries, and 
weighed. The number and position of live and resorbed 
fetuses were recorded. 
Fetal Examination and Preparation 
Each fetus and placenta was removed from the uterus 
and dried on absorbent paper, weighed and examined for 
external malformations. The brain, liver and both kidneys 
1Becton-Dickinson and Co., Rutherford, NJ. 
22 
were removed from each fetus. The composite collection of 
each fetal organ (except brain) constituted a pooled 
sample which was weighed and analyzed for lead. 
Immediately following fetal decapitation, the brain 
was quickly placed in pre,-weighed and labeled scintillation 
vials and frozen on dry ice. The brain samples were then 
transferred to a storage freezer and maintained frozen until 
DNA analysis. 
The rat fetuses harvested on day 20 of gestation were 
examined under a dissecting microscope.for developmental 
and skeletal abnormalities according to the categories of 
anomalies presented in Appendices B and c. Prior to cate-
gorizing, the fetuses were fixed, eviscerated and stained 
in accordance with the procedures outlined in Appendix .·A. 
Tissue Analyses 
A representative sample of fetal and maternal livers. 
and both kidneys of all animals were oven-dried overnight, 
and ashed in a muffle oven at a·bout 500°C. The lead in 
these samples was dissolved with 2 N hydrochloric acid and 
analyzed using a Perkin-Elmer Model 303 atomic absorption 
spectrophotometer. 1 Using known samples, a standard curve 
1Perkin-Elmer, Norwalk, CT. 
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was constructed and the amount of lead in each experimental 
sample was calculated based on this curve (Hyde, et !!.!·.• 
1977) 
A similar atomic absorption technique was used in 
whole blood lead analysis (Hessel, 1968). The blood lead 
was chelated with ammonium pyrrolidine dithiocarbamate and 
extracted into methyl isobutyl ~etone for atomic absorption 
analysis using the spectrophotometer. 
The brain samples maintained in a frozen state 
were lyophilized and reweighed. The remaining dried 
tissue was defatted using two 12-hour extractions with 
chloroform :methanol (2:1), followeid·by two 12-hour ether 
extractions. Th_e dried fat-free tissue (DFFT.) was weighed 
and ground to a fine powder in a Wiley mill. Samples were 
then stored in a desiccator.until analyzed for DNA. DNA was 
extracted with TCA by the method of Schneider (1945) • DNA 
·content in the DFFT was determined using Burton's diphenyl-
amine method (1956). These procedures for preparation and 
analysis are found in Appendix D. 
Data Handling 
Rats which failed to conceive were not included in the 
statistical analysis with rats having viable fetuses. Each 
rat or litter was considered an experimental unit receiving 
24 
one.of the four experimental treatments. A two-way 
analysis of variance, with treatments and replications 
as main effects, and trsatment by replication as the appro-
priate interaction term, was used to compare the four 
different treatments. The critical value of a was set at 
.025 ~priori to insure against chance production of a sig-
nificant test due to the large.number of analyses. 
To allow for an equal number of subjects per repli-
cate within each treatment level, the four lightest an;i.mals 
were removed from the experimental design prior to treat-
ment and replication assignment. Animals were then randomly 
assigned to one of.the twelve cells formed in the treatment 
by replication ~atrix so that all cells contained an equal 
number of sUbjects (N=3). 
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RESULTS 
Gross physical examination and dissecting microscope 
examination using skeletal staining revealed no fetal 
teratogenic malformations. Small developmental differences 
were noted.across pups·as shown in Figure 2 •. These 
differences were in degree of ossification in caudal 
vertebrae.and sternebrae. The numbers of ossified caudal 
vertebrae varied between 2 and 3 present and the number of 
ossified sternebrae varied between 2 and 5 present. Fetuses 
from two dams, control animal 10, and 100 mg/kg treatment 
animal 24, appeared more advanced than others as the cranial 
bones (frontal, parietal and·intraparietal) were starting to 
fuse together ana sternebrae were more· completely ossified as 
seen in Figure 2. All other exposed and control fetuses 
examined, using the criterion found in Appendices C and D, 
appeared to be at day 20 of their gestational period. 
Tables 1 and 2 present the means (±S.E.) for each 
treatment group over each of the dependent measures taken 
for analysis, and includes the significance level for each 
respective analysis of variance. All.significant differences 
pertain to ·effects of treatment only. That is, no signifi-
cant effects of replication or the treatment by replication 
interaction were obtained from any sets of data analyzed. 
Figure 2. . Fetal S.keletal Staining 
A. Varied degrees of sternebrae ossification 
viewed irt most fetal rats at day 20 of 
gestation and dep.i.cted by animal 2. 
B. Advanced sternebrae ossification as seen 
in animals 10 and 24 and. exemplified by 
animal 24. 
c. Cranial bones as typically seen in most · 
fetal rats at day 20 of gestation and 
shown here by animal 2. 
b. Cranial bones in advanced ossification 
as seen in animals 10 and 24 ·and depicted 
by animal 10. 
Arrows indicate sites for comparison. 
/,, 
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Table 1. Kidney and liver weigh,ts and lead concentrations (ppm) in lead exposed 
and control rats 
Treatilient ievel: 
Control 0 50 75 100 Signif-
(mg/kg) (mg/kg) (mg/kg) (mg/kg) icance 
:~~inC~p~f dney 0.78±0.1 18.99±1.71 22.59±2.04 26.21±2.80 :P=.0001 
~:~~inC~p!iver 0.90±0.12 2.09±0.20 2.57±0.32 3 .• 63±0. 27 P=.0001 
Fetal kidney leada,b 0.6 ±Q.26 5.93±0.35 5.9 ±0.46 5.63±0.07 P=.0007 
(ppm) 
Fetal. liver leada,b I. 01±0.17 1.49±0.31 1.67±0.21 2.33±0.27. P=.006 
(ppm) 
Miiterni!llckidney 2.0 ±0.01. 2.22±0.11 ·2.35±0.51 2.35±0.09 NS 
weight ' (g) · 
Matern~l liver 13 .13±0.40 14.31±0.35 14.31±0.53 15.77±1.38 NS 
weight ,c (g) 
'· 
Fetal ki~:SY 
weighta' ' (mg) 
Fetal liger 
weight ' ,c (mg) 
23.73±0.00 22.24±0.00 27.95±0.00 23.64±0.00 
272.00±0.05 237.52±0.02 231.71±0.12 237.29±0.02 
aMean and S.E. 
b 
Pooled fetal sample 
cWet weight 
NS 
NS 
"' \0 
Table 2. Tissue weights, breeding attempts, DNA analysis and number of fetuses 
in control and lead exposed rats 
Treatmetit level 
Control 0 50 75 100 Signif-
(mg/kg) (mg/kg) (mg/kg) (mg/kg) icance 
Uterus and cog- 4.71±0.13 3.83±0.26 4.19±0.29 4.25±0.39 NS 
ceptus weight 
(per pup) (g) 
Ovarian weighta,b 11.19±0.00 11.24±0.00 11.71±0.00 '15.23±0.05 NS 
(mg) 
Breeding attempts 1.56±0.18 2.13±0.40 2.89±0.54 3.14±0.40 NS 
Placental weighta,b 68.35±0.02 63.93±0.02 70.73±0.03 65.69±0.02 NS 
(mg) 
Co.nceptus weighta,b 3.35±0.11 3.13±0.13 3.52±0.16 2.73±0.24 P=. 002 
(g) 
Number of viable 9.0 ±0.88 9.13±1.20 8.22±1.41 8.57±1.23 NS 
pupsa-
Number of non- 1.1 ±0.2 2.25±0.60 1.78±0.55 2.42±0.65 NS 
viable pupsa 
' ' 
Fetal br~in 
weighta, ,c (mg) 
Fetal brain DNAa,c 
(mg/g DFFT) 
aMean and S.E. 
bWet weight 
178.40±0.04 
170.78±2.61 
0 Pooled fetal sample 
148.47±0.01 156.81±0.22 
169.5 ±3.23 168.33±8.94 
156.39±0.16 
166.0 ±8.19 
NS· 
NS 
w ..... 
32 
An examination of Tables 1 and 2 indicates _that all 
measures of lead content (ppm) (maternal liver. and kidney-, 
and pooled fetal liver and kidney per dam) showed treat-
ment differences while only one measure of weight (average 
fetal weight per dam) displayed similar differences. 
Generally, the lead exposure at all of the three levels 
used (SO, 7S, and 100 mg/kg) did not appear to affect DNA 
content in brain or any measure outside those pertaining to 
lead content. 
A posteriori mean comparisons, i.e., Scheffe tests 
(Kirk, 1968), were conducted for each group on each of the 
five significant treatment-related effects mentioned above: 
1. Materna_! kidney lead content - all exposed groups 
were found to be equivalent in terms of ppm leadi 
therefore, their-values wet"e pooled and compared 
against the control group, i~e., exposed v. 
unexposed. The exposed animals contained sig-
nificantly more lead in their kidneys than unexpose~ 
controls .(p<.01). 
2. Maternal liver lead content - differences were 
found between all groups in a dose response 
fashion. That is, the 100 mg/kg group contained 
significantly higher lead levels than both the 
7S and SO mg/kg groups (pc.OS and p<.01, 
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respectivel,y) whfch were, however, equivalent. 
All three lead exposed groups contained signifi-
cantly greater amounts of lead than the control 
group (p<.Ol in each case). 
3. Fetal kidney lead content - as with the maternal 
kidney lead content data., all three expqsed groups 
were equivalent and, therefore, pooled to compare 
against the control group. Results indicated 
that the average fetal kidney lead content per 
dam for. an exposed dam was significantly 
great~r than for an unexposed dam (p<. 01) • 
4. Fetal liver lead content - between-group comparison 
showed ~nly the 100 mg/kg v. O mg/kg comparison to 
be significantly different (p<.01). The average 
fetal liver lead content per dam was in a dose 
response fashion but the 50 and 75 mg/~g groups 
were equivalent to both the 0 and 100 mg/kg 
groups. 
5. Conceptus weight - this variable, measured as· an 
average weight per dam, was not consistent across 
groups. That is, the control and 75 mg/kg 
exposed dams had h~gher average conceptus weights 
than the 100 mg/kg dams (p<.05 and p<.01, 
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respectively); however, the average conceptus 
weights for the 50 mg/kg exposed dams were 
equivalent to those of all other group dams. 
The maternal blood lead values sampled at pre-exposure, 
pre-pregnancy, and pregnancy, indicate that three blood 
lead levels and a control level were maintained throughout ' 
·pregnancy (Figure 2). Statistical tests were not conducted 
on the data due to the large number of missing and spurious 
values found throughout the replicates (Appendix Table 6) 
resulting in an uneven number of values per animal. Mean 
values presented in Table 3 represent values based on 
differing numbers of subjects per cell. The data from 
Table 3, graphically presented in Figure 3, present two 
distinct points: first, a uniform background exposure level 
was present in all animals during pre-exposure conditions 
and was maintained in the control group through the remainder 
·of·the experiment; and, second, by the onset of pregnancy, 
blood·lead levels varied across treatment levels and were 
maintained throughout pregnancy. 
Table 3. Blood lead values (mean ± standard error) for each treatment at pre-
exposure, pre-pregnancy exposure, and pregnancy exposure. (Numbers 
in parentheses indicate number of samples per cell on which the mean 
is based) 
Treatment Pre-
level exposure 
(mg/kg) · (µg/dll 
100 
75 
50 
0 
(9) 
6 ± 0 
(9) 
8 ± 1 
(9) 
10 ± 2 
(8) 
6 ± 1 
(µgfdll (µ9/dl) 
(4) 
94± 15 
(5) 
95 ± 10 
(3) 
93 ± 33 
(5) 
7 ± 2 
.I 
(9) 
89 ± 14 
(9) 
7.1 ± 9 
( 9) 
66 ± 14 
(9) 
8 ± 11 
(µg/dll 
week 1 
(4) 
110 ± 14 
(5) 
98 ± 12 
(7) 
63 ± 16 
(7) 
12 ±·1 
Pregnancy· 
(µgfdll 
week 2 
(6) 
83 ± 17 
(8) 
69 ± 13 
(6) 
47 ± 44 
(4) 
9 ± 2 
(µg/a1> 
week 3 
(3) 
84 ± 17 
(8) 
71 ± 12 
(6) 
72 ± 23 
(9) 
8 ± 2 
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aPre-exposure, pre-pregnancy, and pregnancy periods are 
in weeks. Between pre-pregnancy and pregnancy number 
of weeks varies due to breeding attempts. 
Figure 3. Blood lead values v. blood sampling periods 
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DISCUSSION AND CONCLUSIONS 
In the present investigation, thirty-six female rats 
were randomly assigned to one of four treatment groups, 
with three replicates each, and subjected to an oral intake 
of lead (0,-50, 75, and 100 mg/kg, respectively) to deter-
mine the effects on fetal survival and development •. At day 
20 of gestation, having been orally exposed tio .lead for a 
minimum of five weeks, pregnancy was terminated. Analyses 
were subsequently conducted on maternal blood, as well as 
maternal and fetal soft tissues, for lead content. Fetal 
brains were analyzed for tot'al· DNA; fetal skeletal examina-
tion for malformations was conducted; and reproductive 
tract arid conceptus weights were measured. 
The interpretation of the blood lead data is made some-
what difficult by occasional missing or erratic values, 
Although not statistically analyzed, two points were visually 
apparent. First, with the exception of occasional high 
values, a relatively stable control blood lead level was 
maintained throughout the experiment. This indicated that 
background lead exposure from the environment, although ever 
present, was relatively low. Second, the three treatment 
levels showed trends toward three distinct blood 1ead levels. 
Considering the blood values from each animal individually, 
one can see a rapid rise in blood lead levels for the first 
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two weeks of exposure, with all animals tending to reach a 
plateau in blood lead concentration by the onset of preg-
nancy. Since we have no additional information regarding 
the blood levels between pre-exposure and pre-pregnancy, 
one explanation of the nearly identical rise in blood lead 
values for all treatment groups is that this is a nonlinear 
rise. This could be demonstrated by increased sampling 
over this week-duration, possibly shqwing a slow increase 
for the first few days in blood levels indicating deposition 
in soft tissues and bone. Then, having surpassed these 
absorption capacitie·s, a rapid rise to a peak value would 
occur. The fact that nearly identical peak values were 
reached at the (irst sampling could be explained as blood's 
carrying capacity. Since approximately 90 percent of blood 
lead is membrane bound to red blood cells, a finite carrying 
capacity can be reached. These data indicate that at 50 
mg/kg this capacity was saturated; therefore no subsequent 
rise is noted with larger doses of 75 mg/kg or. 100 mg/kg. 
This apparent "maximum carrying capacity" if true, could be 
unique to the rat as higher blood leaa values associated 
with hig~er exposures have been reported in other species 
(Lassen, 1976; Sharma, 1971). The presence of extremely 
erratic values across weeks can be attributed to laboratory 
contamination or error. For example, some fluctuation in 
values could have been induced or brought on because of the 
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application of a macro-technique of blood lead analysis to 
relative micro amounts of blood, i.e., ~ 2 ml. In any event, 
despite the fact that there were occasional. problems in the 
blood analys.es, the results are important because they exem-
plify an attempt to establish a dose-response correlation 
between oral lead intake and ··blood lead values. The data 
prompt one to question the reliance on dosage alone as .. a 
single measure of exposure. our data show blood.lead values 
' 
from one· animal we:r:e consistently higher or lower when com-
pared to others subjected to the same dosage level, indi-
eating the need to monitor both parameters, lead exposure 
and blood lead values. 
The signif~cance of the liver and kidney lead analyses 
are two-fold. First, lead orally introduced was found' in 
the soft tissues as well as. the blood, thereby substantiating 
that maternal animals were indeed exposed to, and absorbed 
·significantly different amounts of, lead (Table 1). ·second, 
the fetal liver and kidney l~ad analyses demonstrate the 
permeability of the placenta to lead, thereby exposing· the 
developing fetus to lead concentrations. 
Nutritional and lead toxicity studies indicate that DNA 
values (total cell numbers) of the rat neonatal brain can be 
significantly reduced post parturition (Michaelson, 1973; 
Zamenhof et al., 1971; Zeman and Stanbrough, 1969). This 
period is known to be a time when neural cells undergo a 
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great increase in total nuinbers, often referred to as the 
"brain growth spurt" (Dobbing and Sands, 1971). During ges-
·tation, later-dividing neurons, especially those in the 
cerebellum, would not undergo as rapid an increase in cell 
numbers as they do during the early postnatal period. There-
fore, nutritional·deficiencies and toxicoses during the pre-
natal phase may not significantly reduce cell numbers (Endo 
et al., 1974). Our DNA data support this hypothesis. 
' 
However, a trend toward decreased fetal brain weights 
respective to lead dosing of dams was visually apparent but 
was not satistically significant by analysis of variance 
(p = .025). 
Although l~ad is a reported teratogen in mice, hamsters, 
and rats, only slight developmental differences between 
animals were observed in this study. These ossification 
differences were attributed to individual animal variations, 
which·supports the conjecture that teratogenic effects 
caused by lead do not· seem to occur under natural routes of 
exposure. That is, those studies which do purport to 
obtain skeletal teratogenic effects from lead exposure may 
in reality be measuring an artifact of experimental tech-
nique,· or, at best, a teratogenic response occurring from 
an unnatural or surgical route of exposure. 
The apparent effects of lead on the reproductive 
system included a significant reduction in conceptus weight 
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in the high dosage (100 mg/kg) treatment rats, as well ~s 
a trend, which approached significance (p = .043), to'o(l'ard 
a greater number of breeding attempts in order to attain 
conception for lead exposed animals. The lack of effect 
on organ weights and litter size further substantiates 
that oral lead exposure failed to greatly influence fetal 
survival and development in rats. 
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SUMMARY 
This experiment is a unique, multifaceted study that 
attempted to evaluate and correlate lead dosage v. blood 
lead values and fetal .rat ·.development. 
Female Long-Evans strain hooded rats were exposed to 
O, SO, 75, and 100 mg/kg of lead via oral gavage from two 
weeks prior to breeding until day 20 of gestation. Blood 
lead values were calculated from wee~ly collected· blood 
samples. Lead analyses were also conducted on the maternal 
and fetal kidneys and livers. Fetal and maternal organ 
weights were recorded along with reproductive tract data. 
Fetal brains were analyzed for DNA content as an indication 
of total cell ntimbers. 
This study confirms other reports in the literature 
that oral exposure to lead does not cause skeletal terato~ 
genie effects in rats. This study further indicates that in 
the rat, oral exposure of up to 100 mg/kg does not cause 
fetal death or abnormalities. The experimental data obtained 
in this study showed no lead induced reduction in total cell 
numbers in the fetal rat brain. 
Our data also indicate that it is highly desirable to 
monitor levels of exposure and blood lead concentrations to 
obtain a more complete indication of lead exposure in the 
rat. 
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APPENDIX A 
Fetal Skeletal Staining Procedure 
Solutions 
A. Potassium hydroxide 1% aqueous 
B •. Alizarin Red S. 
Potassium hydroxide 
Distilled water 
c. MALL' s solution: 
Technique 
Glycerin 
Distilled water 
Potassium hydroxide 
0.1 gram 
10 grams 
l liter 
20 ml 
79 ml 
l.gram 
1. Fix whole specimens in 95% alcohol for at least 
3 days. 
2. Transfer to acetone and leave for several days to 
dissolve out the fats which would otherwise stain 
intensely and obscure the view of the bony structures. 
3. Wash well with 95% alcohol; then immerse in 95% alcohol 
for 24 hours. 
4. Immerse in solution A from l to 7 days, according to 
the size of the specimen, until the bones are clearly 
visible through the muscle. 
5. Transfer to solution B until the bones are stained the 
desired depth of color. This takes from l to 7 days 
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and the solution should be changed on the fourth day. 
6. Clear in solution c until no more color comes out. 
7. Pass into a mixtu:i:-e of equal parts of glycerin_ and 
water. Gradually increase the glycerin percentage 
through 3-4 passes until concentration is pure glycerin. 
8. Store in pure glycerin. 
Bones are stained red; soft tissue is transparent and 
unstained. 
Notes 
If the initial cleaning in potassium hydroxide solution 
has progressed to the proper stage, only the bone will be 
stained, but otherwise soft tissue will also be stained • 
. The prolonged preiiminary fixation in alcohol renders 
the tissue less. liable to maceration in the potassium hy-
droxide solution. 
Objects fixed in liquids other than alcohol may be 
stained by this method provi~ed they are soaked in 90% 
alcohol for at least 3 days. 
The technique is particularly suitable for demon-
strating developing bone. 
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APPENDIX B 
Categories-of Anomalies 
Developmental 
1. Developmental Failure - Primordium fails to appear or 
does not develop to a significant degree as a whoie. 
Agenesis designates this condition. Examples: absence 
of whole arm (or of radius or hand); absence of kidney. 
2. Developmental Arrest - Progressive d·evelopment falls 
short of nornial condition: cleft palate; double uterus; 
umbilical hernia. Normal growth· halts; dwarfism. 
3. Developmental .Excess' - Growth is exaggerated: gigantism •. 
Normal numbers are increased: extra digits; double 
penis; true twin. Processes exceed normalities; 
extensive hairy coat; thick epidermis (ichthyosis). 
4. Fusion or Splitting - Examples: horseshoe kidney; cleft 
ureter •. 
5. Failure to Subdivide - Retention of common, primitive 
fields; fused eyes (cyclopia), fingers (syndactyl) or 
thighs (sympodia). 
6. Failure to Atrophy - Normally, the temporary features 
remain; anal membrane; cervical fistula; double vena 
cava. 
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7 •. Failure to Consolidate - Examples: lobed or accessory 
spleen, pancreas or suprarenal gland •. 
8. Incorrect Migration - Normal shift fails whol.ly or in 
part; undescended testis; unascehded kidney; fused. 
ears. Normal shift is exceeded; ovary in external 
genitalia. 
9. Misplacement - Organs occupy unexpected locations; 
transposed viscera; palatine teeth. 
10. Atypical Differentiation - The developmental course and 
end product are unlike that in the normal fetus; 
congenital tumors osteogenesis. · 
11. Atavism - Ancestral recurrences: azygos lobed lung, 
elevator muscle of clavicle (as in climbing primates). 
(From Developmental Anatomy, 6th Ed., by Leslie Arey; 
pp. 183-184). 
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APPENDIX C 
Check List of Bones 
Ossified and Incomplete 
Bone 
Nasal 
Premaxilla 
Maxilla 
Zygoma 
Palatine 
Vomer 
Lacrimal 
Frontal 
Parietal 
Interparietal 
Basisphenoid 
Presphenoid 
Occipital 
Description 
Nearly complete, pale center area 
Nearly complete, pale anterior· 
lateral area 
Fusion of 3 segments 
Well defined, not fused 
Not colored 
Not present 
Not .present 
(Dorsally) meets anterior, incom-
plete more posterior 
Nearly complete except a small 
portion dorsally 
Present 
Flat plate + Pterygoid ) ali-
Processes sphe-
also lateral posterior ) noids 
processes 
Beginning 
present 
4 parts - 1 ventral, 2 posterior, 
1 dorsal 
Bone 
Squamosal 
Periotic capsules 
Tympanic bulla 
Ossicles 
Turbinates 
Hyo id 
Mandible 
Cervical 
Thoracic 
Lumbar 
Sacral 
Caudal 
Sternebra 
Clavicle 
Scapula 
Humerus 
Radius and ulna 
Carpals 
.Metacarpals 
Phalanges 
Ilium, ischium, pubis 
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Description 
Present with zygomatic process 
Semicircle anterior - medial -
posterior 
Not present 
Not present 
Not present 
Present ventral basisphenoid 
Well defined 
No centra 
Centra present - each vertebra of 
3 unfused parts 
6 present + unf used centra· 
4 present + unfused centra 
3 present 
2 to 5 present 
Present 
Spine even more defined 
Present 
Trochlear notch becoming visible· 
Not present 
3 most lateral 
Not present 
Well defined 
Bone 
Femur, fibia, fibula 
Tarsals 
Metatarsals 
58 . 
Description 
Assuming normal characteristics 
Not present 
· 4 most lateral 
y· 
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APPENDIX D 
Preparation of Dried Fat-free Tissue . (DFFT) 
(Schneider, 1945) 
1. Approximately 2 g of ·brain tissue was thawed,· minced 
and weighed into a tared sample ja:r. 
2. The samples were freeze-dried for about 24-36 hours. 
3. They were then weighed and the loss due to water was 
determined. 
4. The tissue was extracted twice with 50 ml of chloroform: 
methanol ( 2: 1) for 12 ho.urs each 'time under constant 
agitation with a wrist action sha.ker. 
5; The tissue.was then extracted twice with diethyl ether 
for 12 hours while under agitation. 
6. The solvent was poured off and the tissue allowed to air 
dry for 12 hours before oven drying it at:..so 0 c for 2 
days. 
7. The DFFT was weighed and the loss due to lipid was 
determined. 
8. The tissue was ground to a fine powder in a Wiley mill 
equipped with a No. 40 sieve, oven-dried at 50°C for 
2 days, and placed in a desiccator until ready.for use. 
Procedure 
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Extraction of Total Nucleic Acids 
(Schneider, 1945) 
1. Samples of DFFT (25 mg) were placed in centrifuge 
tubes. .To each tube was added 4.5 ml of 5% TCA. 
2. The.material was allowed to stand. for about 2 hours 
until all the tissue was saturated. 
3. The tubes were placed in a 90°C water bath for 15 
minutes, then cooled and centrifuged for 10 minutes 
at 3,500 x ~ at 4°C. This treatment quantitatively 
dissociates the DNA and RNA from the tissue proteins 
and leaves the protein in an insoluble residue which is 
removed by centrifugation. 
4. The supernatant was poured into a graduated conical 
centrifuge tube. 
5. The residue was resuspended in 4.5 ml of 5% TCA, placed 
in a 90°C water bath for 15 minutes, cooled and centri-
fuged as before. 
6. The decant from the second digest was combined with that 
.from the first extraction. 
7. The combined extracts which constitute the nucleic acid 
fraction of the brain tissue were diluted to a total 
volume of 10 ml with 5% TCA. 
Reagents 
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Determination of DNA Prepared from DFFT 
(Burton, 1956) 
1. Diphenylamine reagent: 1.5 g of diphenylamine was 
dissolved into 100 ml of glacial acetic acid. This 
reagent was prepared on the day it was to be used. Just 
before use, 0.5 ml of aqueous acetaldehyde (16 mg/ml) 
was added to the reagent. 
2. 1 N perchloric acid: Concentrated.(70%) perchloric acid 
(9 ml) was added to 91 ml of distilled water. 
3. Standard: The standard was prepared from calf thymus 
DNA. Dilutions· ranged from 10.0 µg to 400 µg DNA. 
Procedure 
1. Aliquots of standard and nucleic acid extract were 
diluted to 1 ml with 5% TCA. 
2. To each tube was added 1 N perchloric (1 ml) acid and 
diphenylamine reagent (4 ml). The solution was mixed. 
3. Color development occurred by incubating the samples in. 
a 30°C water bath for 16-20 hours. 
4. Absorbance was determined at 600 nm on a Gilford Model 
2000 recording spectrophotometer. 
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APPENDIX E 
Additional Tables of Raw Data 
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Tab:j.e 4. Maternal kidney and· liver weights and lead concen-
trations (ppm) ih lead .exposed .and c.ontrol rats 
Maternal Maternal Maternal Maternal 
Treatment kidney liver kidney liver 
Animal level weight weight lead lead 
Number (mg/kg) (g) (g) (ppm) (ppm) 
5. 100 2.63 25.58 11.l 3.7 
9 100 2.20 15.29 32.B 3.0 
2 100 1. 87 17.02 .27.0 3.4 
39 100 2.47 16.94 22.B 2.7 
26 100 2.00 13.21 . 23. 6 3.2 . 
3 100 2.65 13.15 - 3.4 
37 100 2.43 14.61 28.9 2.9 
12 100 2.42 10.97 25.5 5.4 
29 100 2.51 15.15 38.0 4.1 
24 75 2.63 14.63 32.6 2.5 
13 75 1.63 12.29 22.l 2.5 
11 75 1.97 13.97 28.9 2.5 
34 75 2.70 16.60 23.0 2.2 
14 75 2.71 14.50 25.9 3.0 
4 75 2.14 11.98 14.5 4.9 
38 75 3. OB 16.19 23.7 2.1 
35 75 2.17 13.46 15.6 1.7 
33 ' 75 2.15 15.18 17.0 1.7 
32 50 1.98 13.69 20.0 2.4 
23 50 1.81 14.86 22.6 l. 5 ' 
21 50 1.93 13. 74 ' 24.3 3.0 
22 50 2.84 14.18 25.9 2.8 
25 .50 2.45 12.83 14.9 2.0 
B 50 2.17 15.78 21.5 2.4 
15 so 2.09 16.04 15.9 1.8 
l 50 2.32 13.64 15~5 1.7 
30 50 2.39 14,04 10.3 1.2 
20 0 1. 68 12.31 0.7 1.0 
36 0 1.84 12.13 1.3 1.5 
27 0 2.32 14 •. 36 0.7 0.5 
16 0 1 •. 82 13.76 1.1 0.8 
7 0 1.99 11.58 0.8 0.7 
10 0 2.12 13.20 0.4 1.4 
31 0 1.94 14.72 0.4 0.5 
17 0 2.30 11.85 0.8 0.7 
19 0 1.98 14.24 0.8 1.0 
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Table 5. Total fetal liver and kidney weights and lead con-
centrations. (ppm) in lead expo.sea and c.ontrol rats 
Treat- Fetal Fetal Fetal Fetal 
ment liver kidney liver kidpey 
Animal level weight weight lead lead 
Number (mg/kg) (g) (g) (g) (g)a 
5 100 
9 100 1.70 0.188 3.0 5.8 
2 100 2.07 0.259 2.4 
39 100 2.05 0.162 2.8 
26 100 1.49 0.136 2.6 5.5 
3 100 
37 100 . 1. 87 0.231 2.8 
12 100 0.28 0.252 1.1 5.6 
29 100 2.36 0.184 1.6 
24 75 0.95 0.115 1.4 
13 75 1.96 0.212 2.0 3.3 
11 75 1.67 0.189 3.2 
34 75 0.21 0.047 1.6 
14 75 1.93 0.257 1.1 7.2 
4 75 0.68 0.068 1.5 
38 75 1.85 0.231 1.6 
35 75 1.78 .0 .165 1.3 5.2 
33 75 2.70 0.215 1.4 
32 50. 1.77 0.171 2.2 
.23 50 1.52 0.201 1.2 6.5 
21 50 1.10 0 .116 . 2.4 
22 50 
25 50 0.57 0.046 0.5 7.5 
8 50 2.37 0.202 0.9 
15 50 2.27 0.191 2.4 
1 50 2.75 0,251 0.4 4.1 
30 50 2.39 0.201 1.6 
20 0 1.25 0.116 2.0 
36 0 1.36 0.118 0.8 0.5 
27 0 1.93 0.112· 0.5 
16 0 1.08 0.104 1.2 
7 0 2.29 0.208 0.7 1.0 
10 0 2.55 0.199 0.9 
31 0 1.42 0.200 1.0 
17 0 1 •. 44 0.100 1.6 0.3 
19 0 1.48 0.126 0.4 
aValues for pooled samples in each replicate 
Table 6. Blood lead values of the respective rats 
Pre- Pre-
e:KEosure gestation Gestation 
Treat- Week Week' week Week Week Week ment 
Animal· level 1 2 
3 .. 4 5 6 
Number (mg/kg) (µg/l nil) 
5 100 0.05 0.71 0.74 nga ng ngb 
9 100 .0.05 0.74 o. 91 o. 75 . 0.60 le 
2 100 0,05 1. 34 1.69 1.02 0.83 0.70 
39 100 0.08 4.32° 0.88 le 0.72 le 
26 100 0 .• 07 0.97 0~57 le 0 .• BO le 
3 100 0.06 c 1.18 1.6.J ng .ng ng r '·· 
37 100 0.06 le 0.36 1.27 . l".48 le 
l.2 100 0.05 le 1 •. 23 1.36 le 1.18 
29 100 0.05 le· 0.49 le 0.54 0.63 
24 75 0.11 0.79 0.90 0.93 0.88 0.89 
13 75 0.08 1 .• 06 1.13 0.77 0.51 0.48 
11 75 0.06 1.21 0.82 l.. 32' 0.87 0.85 
34 75 0.09 0.65 0.67 0.67 le 0.61 
14 75 O.l.4 1.02 0.99 1.21 1.46 1.44 
4 75 0.10 c 0.66 le o .• 42 le 0.03 
38 75 0 .03• le 0.44 le 0.52 0.52 
35 75 0.05 le 0.47 le 0.50 o.49 
33 75 0.06 le 0.35 le 0.33 0.36 
32 50 0.09 0.55 . 0. 78 0.55 0.56 le 
23 50 0.11 1.51° 1.01 0.90 0.40 0.61 
21 50 0.05 0.65 0.72 0.59 0.59 0.70 
22 50 0.07 0.87c 0.51 ng ng ng 
25 50 0.15 l.22C 0.51 0;23 le 1;13c 
8 50 0.27 1.60 1.57 1.44 le 1.83 
15 50 0.03 le 0.45 l'e o.·55 0.49 
1 50 0.06 le 0.29 0.43 Ci.34 o·. 37 
30 50 0.08 le 0.13 0.30 .0.39 0.37 
20 0 0.05 0.07 0. 0.7 0.07 le. 0.07 . 
36 0 0.03 0.11 0.11 0 .10. o. 08 0.06 
27 0 . o. 05 0.11 0. 06 0.14 0.05 0.04 
10 0 0.06 0.37C 0.06 le le 0.02 
7 0 0.27c o·~ o4 0.04 0.12 le 0.13 
16 0 0.15 0.02 0.13 0.10 le o.15 
31 0 0.05 le 0 .04. 0.15 0.12c 0.03 "' 17 0 0.06 le 0.13 0.14 0.25 0.00 ·cl'\ 
19 0 0.05 le 0.07 le 0.10 0.12 
a ng = No gestation 
ble = Laboratory analysis error 
cvalue not included in statistical analysis 
Table 7. Maternal reproductive tract and fetal data in 
lead exposed and control rats 
Uterus and 
. a 
Viable 
Treat- Number ovarian conceptus conceptu13 
ment of wet wet wet 
Animal level breeding weight weight weight 
Number (mg/kg) . attempts (mg) . (g) (g) 
5 100 10c 521.3 
9 100 3 116.2 53.28 2.98 
2 100 2 101.6 ·56.65 3.45. 
39 100 3 128.4 60.44 3.06 
26 100 2 117.1 38.66 3.13 
3 100 · 1oc 51. 8 
37 100 3 120. 0 37.92 2.66 
12 100 4 . 95. 7 11.80 1.86 
29 100 5 118.7 50.29 2.00 
24 75 6 121. 7 43.42 3.23 
13. 75 2 95.8 50.47 3 •. 43 
11 75 2 115.6 52.88 3.38 
34 75 3 113;1 lS.50 4.53 
14 75 5 li7.2 47.25 3.18 
4 75 2 .119. 8 23.25 4.09 
38 75 3 144. 0 41.54 3.45 
35 75 2 112.8 41.96 3.06 
33 75 1 113. 5 66.98 3.35 
32 50 2 120.0 41.84 3.62 
23 50 3 99.8 42.94 2.65 
21 50 1 115.7 28.71 3.13 
22 50 lOc 52. 6 
25 50 3· 135. 4 18.04 2.58 
8 50 4 137. 5 55.50 3.20 
15 50 2 113.8 49.13 3.19 
1 50 1 124. 9 65.77 3.26 
30 50 1 112.4 52.84 3.45 
aMean 
bTotal pooled value 
cNot included in statistical test 
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Viable a Totalb 
Fetalb pla- Number fetal 
cental · - ··Number o.f brain brain 
wet of non- wet DNA 
weight viable viable weight (mg/g 
(mg) pups pups (g) DFFT) 
628.8 8 4 0.93 174 
675.5 11 2 1 •. 58 164 
673.0 10 2 1.41 185 
676 .3 8 5 .1. 00 166 
..,. 
74~~4 9 3 1.. 36 121 
59,5.0 2 0 0.13 167 
625.8 12 1 1.62 185 
726. 7 6 4 1. 06 109 
649;0 10 2 1.34 176 
614.6 il 2 1.54 164 
86 o.o 1 4 0.17 169 
72i. 7 12 0 1.14 201 
823.3 3 ·3 0.05 196 
731.2 8 0 1.05 157 
596. 7 9 1 1.14 162 
64 2 .9. 14 0 2.03 .1.81 
725.0 8 2 1.02 174 
53 9.0 10 1 1.19 186 
616. 7 6 5 0.60 158 - - - - -
563.3 3 3 0.32 169 
691.8 11 1 1.47 167 
683.0 10 4 1.29 177 
607.1 14 1 1.96 163 
608.2 11 1 1.57 162 
Table 7 (continued) 
Uterus and Viable a 
Treat- Number Ovarian . conceptus conceptus 
ment · of wet wet wet 
Animal level breeding weig'}l.t weight weight 
Number (mg/kg) . attempts (mg). (g) (g) 
20 0 1 107 .1 38.12 3.50 
36 0 2 100., 53.20 3.10 
27 0 2 111. 5 -:S0.74 3.85 
16 0 1 121. 9 61.70 3 •. 15 
7 0 l· 110.l 58.82 2 .• 84 
10 0 2 136.5 35.92 3.36 
31 0 2 104. 9 47.22 3.;!2 
17 0 2 106. 0 31.87 3.41 
19 0 1 107. 9 48.31 3.73 
.1 
I 
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Viable a Totalb 
pla- Number fetal .Fetalb 
cental Number of brain brain 
wet ·of non- wet DNA 
weight ·viable viable weight Cmg/g 
(mg) pupio pups (g) DFFT) 
657.l 7 2 0. 71 . 171 
604 .• 4 ·9 2 1.16 162 
752.2 ·9 1 1.23 182 
633.1 13 1 1.79 174 
672.3 13 0 .l.51 164 
125 .·o . "6 1 0.70 183 
635.·o . 10 1 0 •. 99 170 
760.0 6 1 0.68 162 
712 .• :5 8 1 1.08 169 
